octreotide-conjugated paclitaxel

created by coupling taxol-succinate to the amino-terminal end of octreotide which retains the biological activity of taxol in inducing formation of tubulin bundles, eventually causing apoptosis of MCF-7 cells; structure in first source

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Chen, S T: 1 article (07/2000)
2.	Huang, C M: 1 article (07/2000)
3.	Wu, Y T: 1 article (07/2000)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2000 - "Our results strongly indicated that octreotide-conjugated taxol demonstrates cell selectivity and may be used as a targeting agent for cancer therapy."

Related Therapies and Procedures

1.	Therapeutics